This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Ecolab Scientist Kirsten Thompson Discusses Healthcare-associated Infections (HAIs) And How OxyCide Daily Disinfectant Cleaner Can Help Eliminate The Bacteria And Viruses That Can Cause HAIs

Stocks in this article: ECL

Ecolab introduces OxyCide™ Daily Disinfectant Cleaner, a non-bleach sporicide developed for daily use in healthcare settings. OxyCide is proven effective in killing a broad spectrum of harmful bacteria and viruses, including Clostridium difficile ( C. difficile) spores in three minutes and multi-drug resistant organisms and viruses in five minutes or less, helping hospitals to reduce the risk of healthcare-associated infections (HAIs).

Frequently, pathogens travel between environmental surfaces, hands and ultimately to patients, causing infections. According to the Centers for Disease Control and Prevention (CDC), approximately 1.7 million patients contract HAIs in U.S. hospitals every year, of which 14,000 die of C. difficile infections. Preventing the spread of C. difficile is particularly difficult because its spores are resistant to standard disinfectants and can live on hard surfaces for months. According to a recent study in Journal of the American Medical Association Internal Medicine, C. difficile infections cost the healthcare industry $1.5 billion each year, or approximately $11,285 per case.

“OxyCide is proven to kill 33 different types of bacteria and viruses in five minutes or less and will help generate efficiency gains and savings in hospitals by eliminating the need to use multiple solutions on the different surfaces within operating rooms, patient rooms and common areas,” said Dr. Andy Cooper, vice president of Research, Development & Engineering at Ecolab. “Using a sporicide everywhere, everyday will help our customers be more effective in killing C. difficile spores and other dangerous pathogens.”

In a study presented at IDWeek 2012, daily cleaning using OxyCide resulted in a 36.5 percent reduction of viable bacteria on hospital surfaces compared to other disinfectants. i OxyCide leaves no visible residue and, unlike bleach, does not require rinsing. It is non-corrosive on most hard surfaces, including high-touch objects such as over-bed tables, bedrails, door handles and bathroom surfaces. In addition, OxyCide’s lockable product cabinet and closed-loop dispensing system offer safer product handling for staff, helping to reduce the risk of spills by eliminating the need for manual pouring and mixing.

According to a January 2013 survey from the Association of Professionals in Infection Control and Epidemiology (APIC), 70 percent of infection preventionists have adopted additional interventions in their facilities to address C. difficile since March 2010, however only 42 percent have seen a decline in their infection rates. ii In addition, the Centers for Medicare & Medicaid Services have begun requesting C. difficile infection data from hospitals this year and potentially could reduce reimbursements related to infections caused by the bacteria.

OxyCide is being featured at the Association for the Healthcare Environment (AHE) EXCHANGE 2013 meeting in Indianapolis. For more information, visit the OxyCide Daily Disinfectant Cleaner page on Ecolab.com.

About EcolabA trusted partner at more than one million customer locations, Ecolab (ECL) is the global leader in water, hygiene and energy technologies and services that protect people and vital resources. With 2012 sales of $12 billion and 44,000 associates, Ecolab delivers comprehensive solutions and on-site service to promote safe food, maintain clean environments, optimize water and energy use and improve operational efficiencies for customers in the food, healthcare, energy, hospitality and industrial markets in more than 170 countries around the world.

For more news and information, visit www.ecolab.com.

Follow us on Twitter @ecolab or Facebook at facebook.com/ecolab.

i Perkins J, Ferguson J, et. al. Effect on Patient Room Environmental Bioburden From Use of a Novel Daily-Use Sporicidal Hard Surface Disinfectant. Poster; IDWeek 2012, San Diego, CA – October 17-21, 2012.

ii Association of Professionals in Infection Control and Epidemiology. “2013 CDI Pace of Progress Survey”. January 2013. http://cdiff2013.site.apic.org/about-the-conference/cdi-pace-of-progress-survey/.

(ECL-P)

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs